Cargando…

Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa

Background. It is unknown what properties would be required to make an intervention in low income countries that can eradicate or control human immunodeficiency virus (HIV) without antiretroviral therapy (ART) cost-effective. Methods. We used a model of HIV and ART to investigate the effect of intro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phillips, Andrew N., Cambiano, Valentina, Revill, Paul, Nakagawa, Fumiyo, Lundgren, Jens D., Bansi-Matharu, Loveleen, Mabugu, Travor, Sculpher, Mark, Garnett, Geoff, Staprans, Silvija, Becker, Stephen, Murungu, Joseph, Lewin, Sharon R., Deeks, Steven G., Hallett, Timothy B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907418/ https://www.ncbi.nlm.nih.gov/pubmed/27034345 http://dx.doi.org/10.1093/infdis/jiw120

Ejemplares similares

Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile
por: Phillips, Andrew N., et al.
Publicado: (2016)

Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa
por: Phillips, Andrew N, et al.
Publicado: (2016)

Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries
por: Cambiano, Valentina, et al.
Publicado: (2015)

The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis
por: Phillips, Andrew N, et al.
Publicado: (2021)

Potential Impact and Cost-Effectiveness of Condomless-Sex–Concentrated PrEP in KwaZulu-Natal Accounting for Drug Resistance
por: Phillips, Andrew N, et al.
Publicado: (2019)

Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings
por: Phillips, Andrew, et al.
Publicado: (2014)

Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2018)

Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure
por: Shroufi, Amir, et al.
Publicado: (2019)

Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa
por: Phillips, Andrew N., et al.
Publicado: (2017)

Cost‐per‐diagnosis as a metric for monitoring cost‐effectiveness of HIV testing programmes in low‐income settings in southern Africa: health economic and modelling analysis
por: Phillips, Andrew N, et al.
Publicado: (2019)

Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines
por: Phillips, Andrew N, et al.
Publicado: (2020)

Reflecting the real value of health care resources in modelling and cost-effectiveness studies—The example of viral load informed differentiated care
por: Revill, Paul, et al.
Publicado: (2018)

Opportunities for improving the efficiency of paediatric HIV treatment programmes
por: Revill, Paul A., et al.
Publicado: (2015)

Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design
por: Lau, Jillian S Y, et al.
Publicado: (2022)

Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models
por: Bershteyn, Anna, et al.
Publicado: (2022)

Cost-effectiveness of voluntary medical male circumcision for HIV prevention across sub-Saharan Africa: results from five independent models
por: Bansi-Matharu, Loveleen, et al.
Publicado: (2022)

Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2017)

Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting
por: Greenberg, Lauren, et al.
Publicado: (2022)

Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models
por: Jewell, Britta L, et al.
Publicado: (2020)

90‐90‐90 by 2020? Estimation and projection of the adult HIV epidemic and ART programme in Zimbabwe – 2017 to 2020
por: Bansi‐Matharu, Loveleen, et al.
Publicado: (2018)

Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2022)

Strengthening the scale‐up and uptake of effective interventions for sex workers for population impact in Zimbabwe
por: Cowan, Frances M, et al.
Publicado: (2019)

A quantitative assessment of the consistency of projections from five mathematical models of the HIV epidemic in South Africa: a model comparison study
por: Moolla, Haroon, et al.
Publicado: (2023)

Potential Future Impact of a Partially Effective HIV Vaccine in a Southern African Setting
por: Phillips, Andrew N., et al.
Publicado: (2014)

The Potential Impact of Long-Acting Cabotegravir for HIV Prevention in South Africa: A Mathematical Modeling Study
por: Smith, Jennifer A, et al.
Publicado: (2020)

The Distribution of Sex Acts and Condom Use within Partnerships in a Rural Sub-Saharan African Population
por: Smith, Jennifer, et al.
Publicado: (2014)

Projected Lifetime Healthcare Costs Associated with HIV Infection
por: Nakagawa, Fumiyo, et al.
Publicado: (2015)

Reductions in HIV incidence are likely to increase the importance of key population programmes for HIV control in sub‐Saharan Africa
por: Garnett, Geoff P
Publicado: (2021)

Sonography to Rule Out Tuberculosis in Sub-Saharan Africa: A Prospective Observational Study
por: Ndege, Robert, et al.
Publicado: (2019)

Why are pathogenic SIV and HIV infections characterized by high level immune activation when other chronic virus infection are not? Lessons from nonpathogenic SIV infection in natural host species
por: Staprans, Silvija, et al.
Publicado: (2006)

Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges
por: Regoes, Roland R, et al.
Publicado: (2005)

Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection
por: Collins, Lauren F, et al.
Publicado: (2017)

Sociodemographic differences in symptom severity and duration among women referred to secondary care for menorrhagia in England and Wales: a cohort study from the National Heavy Menstrual Bleeding Audit
por: Kiran, Amit, et al.
Publicado: (2018)

Factors associated with receiving surgical treatment for menorrhagia in England and Wales: findings from a cohort study of the National Heavy Menstrual Bleeding Audit
por: Geary, Rebecca Sally, et al.
Publicado: (2019)

Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
por: Paltiel, A. David, et al.
Publicado: (2017)

Expanding Hepatitis C Virus Care and Cure: National Experience Using a Clinical Pharmacist–Driven Model
por: Koren, David E, et al.
Publicado: (2019)

Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy–Naïve and –Experienced Patients in Sub-Saharan Africa
por: Kalata, Newton, et al.
Publicado: (2021)

Effects of the Coronavirus Disease 2019 Pandemic on Human Immunodeficiency Virus Services: Findings from 11 Sub-Saharan African Countries
por: Harris, Tiffany G, et al.
Publicado: (2021)

Validation of Apolipoprotein A-1 and Fibronectin Fragments as Markers of Parasitological Cure for Congenital Chagas Disease in Children Treated With Benznidazole
por: Ruiz-Lancheros, Elizabeth, et al.
Publicado: (2018)

Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study
por: Pericot-Valverde, Irene, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7e9q7cfld4aehhu1agqek9vdsr